Angiogenesis

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Angiogenesis.php on line 2
Angiogenesis

LE WE PMID CA

Angiogenesis

3854

Angiogenese

ACVRLK1

AGGF1 VG5Q

ALK1

Angiogenesis

Angiopoietin2

Antiinflammatory compounds

Antineoplastic agents (Tumor vascular disrupting agents)

Apoptosis

Arthritis (rheumatoid)

ASA404

Asymmetric dimethylarginine

Atherosclerosis (BASKET)

Autonomous nervous system (BASKET)

Basophils

BDNF

bFGF

Biomarker (BASKET)

Blood vessels (Malformation)

Blood vessels (Pericytes)

Bone (Neoplasia Ewing s sarcoma)

Calsenilin KCNIP3 CSEN DREAM

CD105

CD13 aminopeptidase N

Cell migration

Cell Secretion (Exosomes)

Circulation (Anatomy)

Circulation (Development)

Cloche

CNS (Development)

CNS (Neoplasia Glioma)

CNS (Neoplasia)

COL3A1

DLL4

Double minute2

EGFL7

Endoglin

Endostatin

Endothelial cell (Progenitor)

Endothelium

ENG

Ephrin

Erucin

Eye (Development)

Eye (Retina BASKET)

Factor XIII (Coagulation)

FGF2

Filopodia

FOXC2

Frizzled4

Galectin1

Glomulin

Heart (Coronary heart disease BASKET)

Hedgehog

Hemopoiesis (embryonal)

HGF

Histochemistry

Histone deacetylase

HSP90

Hydrogensulfide

Indinavir

Interleukin24 MDA7

JAM1

JNK

Kidney (Fibrosis)

Klippel Trenaunay syndrome

KRIT1

LRP5 LDL Receptor Related Protein5 Arrow

Lycat

Lymphatics (Development)

Lysyl oxidase

Macrophages

MADH4

Mast cells

Matrix metalloproteinase

MEF2c

MGC4607

MiRNA 126

Morphogenesis (Development)

MRT (Instrumentation)

NADPH oxidase

Nanomedicine

NDP

NEMO

Neoplasia (Electrochemotherapy)

Neoplasia (Invasion and metastasis)

Neoplasia (Tumor biology and immunology)

Nestin

Netrin

Neuroendocrine system (Neoplasia)

NFATc1

NGR pharmacophore

Norrin

Notch

NOTCH3

ORAI1 CRACM1

PCD (Multiple myeloma and other plasma cell dyscrasias)

PDCD10

PTEN MMAC1 TEP1

Pulmonary emphysema

Pulmonary hypertension

Radiation therapy

RASA1

Receptor (Interleukin22)

Receptor (TGF beta family)

Regeneration of tissues and other biologic structures

RNA (MicroRNA)

Sarcoma

Semaphorin

Skin (Neoplasia Melanoma)

SOX18

Sphingosine1 phosphate

SRF

Statin

Stem cell (Adult)

Structure det. tissue level to single molecule localization

Structure determination at molecular level and finer

SU11248

TGF beta

Thrombospondin

Thymidine phosphorylase

Thymosin beta4

Tie2

TIMP2

TIMP3

Transporter (Sodium and proton)

TRPV4

Tspan12

UNC5

VEGF

VEGFR3

Wnt beta Catenin TCF

Wound healing

ZD6126

ZD6474

Zidovudine

2004 1	Therapeutic angiogenesis using vascular endothelial growth factor. [15213090] Asian Cardiovasc Thorac Ann 12(2): 173-81 (2004)
2008 2	Vascular repair by endothelial progenitor cells. [18349136] Cardiovasc Res 78(3): 413-21 (2008)
2008 3	Mechanisms of angiogenesis and remodelling of the microvasculature. [18339645] Cardiovasc Res 78(2): 201-2 (2008)
2008 4	Neural guidance molecules, tip cells, and mechanical factors in vascular development. [18316324] Cardiovasc Res 78(2): 232-41 (2008)
2008 5	Besides adhesion: new perspectives of integrin functions in angiogenesis. [18285512] Cardiovasc Res 78(2): 213-22 (2008)
2008 6	Post-ischaemic neovascularization and inflammation. [18252762] Cardiovasc Res 78(2): 242-9 (2008)
2008 7	Understanding the immunoangiostatic CXC chemokine network. [18252760] Cardiovasc Res 78(2): 250-6 (2008)
2008 8	Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. [18178573] Cardiovasc Res 78(2): 257-64 (2008)
2008 9	Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. [18079100] Cardiovasc Res 78(2): 203-12 (2008)
2008 10	Non-canonical fibroblast growth factor signalling in angiogenesis. [18056763] Cardiovasc Res 78(2): 223-31 (2008)
2005 11	Role of neural guidance signals in blood vessel navigation. [15664389] Cardiovasc Res 65(3): 629-38 (2005)
2005 12	Control of arterial branching morphogenesis in embryogenesis: go with the flow. [15664388] Cardiovasc Res 65(3): 619-28 (2005)
2003 13	Building better blood vessels: new insight on the molecular control of arteriogenesis. [14499852] Cardiovasc Res 59(3): 532-3 (2003)
2003 14	De novo vasculogenesis in the heart. [12757872] Cardiovasc Res 58(2): 378-89 (2003)
2001 15	Platelet-released phospholipids link haemostasis and angiogenesis. [11166272] Cardiovasc Res 49(3): 588-99 (2001)
2001 16	Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. [11166267] Cardiovasc Res 49(3): 543-53 (2001)
2001 17	Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. [11166266] Cardiovasc Res 49(3): 532-42 (2001)
2001 18	Molecular mechanisms of blood vessel growth. [11166264] Cardiovasc Res 49(3): 507-21 (2001)
1998 19	Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis. [9764187] Cardiovasc Res 39(1): 8-33 (1998)
1996 20	Early embryonic vascular development. [8681344] Cardiovasc Res 31 Spec No(-): E34-45 (1996)
2003 21	Designer blood vessels and therapeutic revascularization. [14534146] Br J Pharmacol 140(4): 627-36 (2003)
2003 22	Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis. [14534145] Br J Pharmacol 140(4): 620-6 (2003)
2003 23	Emerging concept in angiogenesis: specification of arterial and venous endothelial cells. [14534144] Br J Pharmacol 140(4): 611-3 (2003)
2003 24	Fishing for novel angiogenic therapies. [14534143] Br J Pharmacol 140(4): 585-94 (2003)
2007 25	Nonclassic endogenous novel [corrected] regulators of angiogenesis. [17540906] Pharmacol Rev 59(2): 185-205 (2007)
2004 26	Vascular endothelial growth factor and angiogenesis. [15602010] Pharmacol Rev 56(4): 549-80 (2004)
2000 27	Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. [10835101] Pharmacol Rev 52(2): 237-68 (2000)
2006 28	The duality of angiogenesis: implications for therapy of human disease. [16983325] J Invest Dermatol 126(10): 2160-6 (2006)
2008 29	Insights into mechanisms behind arteriogenesis: what does the future hold? [18678607] J Leukoc Biol 84(6): 1379-91 (2008)
2001 30	Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. [11590184] J Leukoc Biol 70(4): 478-90 (2001)
1994 31	Macrophages and angiogenesis. [7509844] J Leukoc Biol 55(3): 410-22 (1994)
2004 32	Angiostatin and anti-angiogenic therapy in human disease. [14749498] Recent Prog Horm Res 59(-): 73-104 (2004)
2004 33	Functional significance of Tie2 signaling in the adult vasculature. [14749497] Recent Prog Horm Res 59(-): 51-71 (2004)
2010 34	Stimulation of functional vessel growth by gene therapy. [20473388] Integr Biol (Camb) 2(2-3): 102-12 (2010)
2009 35	Novel insights into the differential functions of Notch ligands in vascular formation. [20016694] J Angiogenes Res 1(-): 8 (2009)
2003 36	Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. [12673346] Acta Biochim Pol 50(1): 49-59 (2003)
2003 37	The enigmatic role of angiopoietin-1 in tumor angiogenesis. [14672554] Cell Res 13(5): 309-17 (2003)
2009 38	Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells. [19544080] Angiogenesis 12(4): 303-11 (2009)
2009 39	Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix. [19449108] Angiogenesis 12(3): 275-85 (2009)
2009 40	Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. [19267251] Angiogenesis 12(2): 177-85 (2009)
2009 41	Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. [19221886] Angiogenesis 12(2): 159-64 (2009)
2009 42	Fibronectins in vascular morphogenesis. [19219555] Angiogenesis 12(2): 165-75 (2009)
2008 43	Lysophosphatidic acid (LPA) and angiogenesis. [18504643] Angiogenesis 11(3): 301-10 (2008)
2008 44	Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells. [18491207] Angiogenesis 11(3): 289-99 (2008)
2008 45	Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. [18415691] Angiogenesis 11(3): 277-88 (2008)
2008 46	Vascular permeability, vascular hyperpermeability and angiogenesis. [18293091] Angiogenesis 11(2): 109-19 (2008)
2004 47	Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. [15609081] Angiogenesis 7(3): 269-76 (2004)
2003 48	Early contribution of pericytes to angiogenic sprouting and tube formation. [15041800] Angiogenesis 6(3): 241-9 (2003)
2009 49	The role of the Angiopoietins in vascular morphogenesis. [19449109] Angiogenesis 12(2): 125-37 (2009)
2009 50	Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1. [19444628] Angiogenesis 12(3): 251-65 (2009)
2009 51	The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. [19399631] Angiogenesis 12(3): 267-74 (2009)
2009 52	Semaphorins and tumor angiogenesis. [19266292] Angiogenesis 12(2): 187-93 (2009)
2009 53	Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in vitro. [19247789] Angiogenesis 12(3): 209-20 (2009)
2009 54	A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. [19214765] Angiogenesis 12(1): 81-90 (2009)
2009 55	Molecular differentiation and specialization of vascular beds. [19212819] Angiogenesis 12(2): 139-47 (2009)
2009 56	Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling. [19194777] Angiogenesis 12(2): 113-23 (2009)
2009 57	Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. [19184477] Angiogenesis 12(1): 47-67 (2009)
2009 58	Morphological and molecular aspects of physiological vascular morphogenesis. [19130273] Angiogenesis 12(2): 101-11 (2009)
2009 59	Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. [19105036] Angiogenesis 12(1): 35-46 (2009)
2008 60	Circulating and imaging markers for angiogenesis. [18925424] Angiogenesis 11(4): 321-35 (2008)
2008 61	PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. [18810647] Angiogenesis 11(4): 361-7 (2008)
2008 62	A role for planar cell polarity signaling in angiogenesis. [18798004] Angiogenesis 11(4): 347-60 (2008)
2008 63	The chick embryo chorioallantoic membrane as a model to study tumor metastasis. [18780151] Angiogenesis 11(4): 311-9 (2008)
2008 64	Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis. [18758974] Angiogenesis 11(4): 337-46 (2008)
2008 65	Mechanisms of adaptive angiogenesis to tissue hypoxia. [18327686] Angiogenesis 11(2): 121-40 (2008)
2008 66	Hedgehog signalling in vascular development. [18301996] Angiogenesis 11(1): 71-7 (2008)
2008 67	Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. [18283547] Angiogenesis 11(1): 31-9 (2008)
2008 68	Endoglin in angiogenesis and vascular diseases. [18283546] Angiogenesis 11(1): 79-89 (2008)
2008 69	Netrins and UNC5 receptors in angiogenesis. [18266062] Angiogenesis 11(1): 23-9 (2008)
2008 70	Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. [18264786] Angiogenesis 11(1): 13-21 (2008)
2008 71	Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. [18256896] Angiogenesis 11(1): 41-51 (2008)
2008 72	Wnt/Frizzled signaling in angiogenesis. [18253847] Angiogenesis 11(1): 63-9 (2008)
2008 73	Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation. [18060510] Angiogenesis 11(2): 153-67 (2008)
2007 74	Aortic rings stimulate inflammatory angiogenesis in a subcutaneous implant in vivo model. [17786574] Angiogenesis 10(4): 287-95 (2007)
2007 75	Angiogenic response of endothelial cells seeded dispersed versus on beads in fibrin gels. [17721825] Angiogenesis 10(4): 269-77 (2007)
2007 76	Thymosin beta4 and angiogenesis: modes of action and therapeutic potential. [17632766] Angiogenesis 10(4): 229-41 (2007)
2007 77	T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells. [17486418] Angiogenesis 10(3): 183-95 (2007)
2007 78	Angiogenesis and chronic inflammation: cause or consequence? [17457680] Angiogenesis 10(3): 149-66 (2007)
2007 79	Combination therapy for the treatment of ocular neovascularization. [17372853] Angiogenesis 10(2): 141-8 (2007)
2007 80	Progenitor cells and retinal angiogenesis. [17372851] Angiogenesis 10(2): 89-101 (2007)
2007 81	Development of the retinal vasculature. [17322966] Angiogenesis 10(2): 77-88 (2007)
2007 82	Regulation of endothelial cell migration by amphiphiles - are changes in cell membrane physical properties involved? [17265099] Angiogenesis 10(1): 13-22 (2007)
2007 83	An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. [17225955] Angiogenesis 10(1): 35-45 (2007)
2007 84	Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2. [17149535] Angiogenesis 10(1): 55-68 (2007)
2007 85	CCN family proteins and angiogenesis: from embryo to adulthood. [17149534] Angiogenesis 10(1): 1-11 (2007)
2006 86	Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis. [17109197] Angiogenesis 9(4): 183-91 (2006)
2006 87	Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue. [17109196] Angiogenesis 9(4): 193-200 (2006)
2006 88	Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. [17109193] Angiogenesis 9(4): 225-30; discussion 231 (2006)
2006 89	Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens. [17109192] Angiogenesis 9(4): 209-24 (2006)
2006 90	Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in fibrin and collagen gels. [17051343] Angiogenesis 9(3): 111-25 (2006)
2006 91	Angiogenesis - understanding the mathematical challenge. [17051342] Angiogenesis 9(3): 127-38 (2006)
2006 92	Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. [17051341] Angiogenesis 9(3): 139-51 (2006)
2005 93	Three-dimensional reconstruction of tumor microvasculature: simultaneous visualization of multiple components in paraffin-embedded tissue. [16328157] Angiogenesis 8(4): 297-305 (2005)
2005 94	Angiogenesis in the human heart: gene and cell therapy. [16308736] Angiogenesis 8(3): 241-51 (2005)
2005 95	Angiogenesis in ischaemic and hypertrophic hearts induced by long-term bradycardia. [16308735] Angiogenesis 8(3): 253-62 (2005)
2005 96	EDB fibronectin and angiogenesis -- a novel mechanistic pathway. [16308732] Angiogenesis 8(3): 183-96 (2005)
2005 97	Vascular morphogenesis in the primate ovary. [16240058] Angiogenesis 8(2): 101-16 (2005)
2005 98	Angiogenesis in normal and neoplastic ovaries. [16211363] Angiogenesis 8(2): 169-82 (2005)
2005 99	Lymphangiogenesis in human gynaecological cancers. [16211357] Angiogenesis 8(2): 137-45 (2005)
2004 100	The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels. [15609077] Angiogenesis 7(3): 225-33 (2004)
2004 101	In vivo videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti-angiogenic agent ZD6474 on vascular function in a liver metastasis model. [15516836] Angiogenesis 7(2): 157-64 (2004)
2004 102	Eph receptor tyrosine kinases in angiogenesis: from development to disease. [15302992] Angiogenesis 7(1): 17-28 (2004)
2004 103	Quantitative angiogenesis assays in vivo--a review. [15302991] Angiogenesis 7(1): 1-16 (2004)
2003 104	A modified chorioallantoic membrane assay allows for specific detection of endothelial apoptosis induced by antiangiogenic substances. [15041801] Angiogenesis 6(3): 251-4 (2003)
2003 105	Discovery and development of anti-angiogenic peptides: A structural link. [14739615] Angiogenesis 6(2): 83-91 (2003)
2003 106	Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF). [14517407] Angiogenesis 6(1): 73-7 (2003)
2002 107	Anti-angiogenic therapy: rationale, challenges and clinical studies. [12906317] Angiogenesis 5(4): 237-56 (2002)
2002 108	Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents. [12549859] Angiogenesis 5(1-2): 45-51 (2002)
2001 109	Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. [11911017] Angiogenesis 4(3): 193-206 (2001)
2001 110	A study of metabolites as intermediate effectors in angiogenesis. [11824381] Angiogenesis 4(1): 71-7 (2001)
2001 111	Improved quantification of angiogenesis in the rat aortic ring assay. [11806245] Angiogenesis 4(2): 133-42 (2001)
2001 112	Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. [11806243] Angiogenesis 4(2): 113-21 (2001)
1999 113	Peroxovanadium compounds as inhibitors of angiogenesis. [14517416] Angiogenesis 3(4): 361-9 (1999)
1999 114	Zebrafish angiogenesis: a new model for drug screening. [14517415] Angiogenesis 3(4): 353-9 (1999)
1999 115	An in vitro model of angiogenesis: basic features. [14517413] Angiogenesis 3(4): 335-44 (1999)
1999 116	A novel method of visualizing vessels in human tumor biopsies. [14517408] Angiogenesis 3(4): 291-3 (1999)
1998 117	Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. [14517471] Angiogenesis 2(2): 153-65 (1998)
1999 118	Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. [14517446] Angiogenesis 3(1): 69-76 (1999)
1999 119	Angiogenesis and ophthalmic disease. [14517440] Angiogenesis 3(1): 9-14 (1999)
1999 120	Role of endothelial cell survival and death signals in angiogenesis. [14517428] Angiogenesis 3(2): 101-16 (1999)
1998 121	Tubular morphogenesis by genotoxic therapeutic agents that induce NF-kappaB activation in human vascular endothelial cells. [14517454] Angiogenesis 2(4): 345-56 (1998)
1998 122	The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. [14517453] Angiogenesis 2(4): 331-44 (1998)
2001 123	Postnatal vasculogenesis. [11165474] Mech Dev 100(2): 157-63 (2001)
2007 124	Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen. [19936090] Gene Regul Syst Bio 1(-): 217-26 (2007)
2008 125	The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. [19123972] BMB Rep 41(12): 833-9 (2008)
2008 126	Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. [18452647] BMB Rep 41(4): 278-86 (2008)
2007 127	Optimized fibrin gel bead assay for the study of angiogenesis. [18978935] J Vis Exp -(3): 186 (2007)
1987 128	Angiostatic steroids. Method of discovery and mechanism of action. [2443088] Ann Surg 206(3): 374-83 (1987)
2001 129	The hemostatic system and angiogenesis in malignancy. [11687948] Neoplasia 3(5): 371-84 (2001)
2006 130	How molecular imaging is speeding up antiangiogenic drug development. [17121909] Mol Cancer Ther 5(11): 2624-33 (2006)
2008 131	VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. [18827808] Br J Cancer 99(8): 1204-9 (2008)
2007 132	Vascular disrupting agents in clinical development. [17375046] Br J Cancer 96(8): 1159-65 (2007)
2006 133	Adrenomedullin and tumour angiogenesis. [16251875] Br J Cancer 94(1): 1-7 (2006)
2005 134	The clinical potential of antiangiogenic fragments of extracellular matrix proteins. [16234821] Br J Cancer 93(9): 967-72 (2005)
2003 135	New molecular pathways in angiogenesis. [12865906] Br J Cancer 89(2): 228-31 (2003)
1995 136	Tumour vasculature--a potential therapeutic target. [7543770] Br J Cancer 72(2): 257-67 (1995)
2005 137	The role of dendritic cell precursors in tumour vasculogenesis. [15785750] Br J Cancer 92(7): 1182-7 (2005)
2000 138	Progress in antiangiogenic gene therapy of cancer. [11002212] Cancer 89(6): 1181-94 (2000)
2007 139	Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. [17908955] Clin Cancer Res 13(19): 5670-4 (2007)
2007 140	Molecular pathways for cancer angioprevention. [17671111] Clin Cancer Res 13(15 Pt 1): 4320-5 (2007)
1996 141	What is the role of thymidine phosphorylase in tumor angiogenesis. [8757181] J Natl Cancer Inst 88(16): 1091-2 (1996)
2008 142	Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. [18754859] Cancer Sci 99(8): 1501-6 (2008)
2008 143	Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies. [18167133] Cancer Sci 99(3): 459-66 (2008)
2006 144	Role of hematopoietic lineage cells as accessory components in blood vessel formation. [16827795] Cancer Sci 97(7): 568-74 (2006)
2004 145	The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. [15546501] Cancer Sci 95(11): 851-7 (2004)
2005 146	Tumor inflammatory angiogenesis and its chemoprevention. [16322203] Cancer Res 65(23): 10637-41 (2005)
2005 147	Endogenous inhibitors of angiogenesis. [15899784] Cancer Res 65(10): 3967-79 (2005)
2000 148	Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. [11114740] Oncogene 19(49): 5598-605 (2000)
1999 149	Growth factor signaling pathways in vascular development. [10630644] Oncogene 18(55): 7917-32 (1999)
1999 150	New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. [10498889] Oncogene 18(38): 5356-62 (1999)
2004 151	Tumor angiogenesis in mice and men. [15153806] Cancer Biol Ther 3(6): 498-500 (2004)
2003 152	Tissue factor signal transduction in angiogenesis. [12807741] Carcinogenesis 24(6): 1009-13 (2003)
2000 153	Tumor angiogenesis: past, present and the near future. [10688871] Carcinogenesis 21(3): 505-15 (2000)
1998 154	Current concepts of tumor-induced angiogenesis. [9555124] Pathol Oncol Res 4(1): 62-75 (1998)
2008 155	A dialogue between the hypoxia-inducible factor and the tumor microenvironment. [19308685] Cancer Microenviron 1(1): 53-68 (2008)
2010 156	Angiogenesis: an update and potential drug approaches (review). [19956828] Int J Oncol 36(1): 5-18 (2010)
2009 157	Development of targeted angiogenic medicine. [18983480] J Thromb Haemost 7(1): 21-33 (2009)
2009 158	Emerging mechanisms of vascular stabilization. [19630769] J Thromb Haemost 7 Suppl 1(-): 57-60 (2009)
2006 159	Factor XIII (FXIII) and angiogenesis. [16129024] J Thromb Haemost 4(1): 19-25 (2006)
2005 160	Angiogenesis: update 2005. [16102050] J Thromb Haemost 3(8): 1835-42 (2005)
1995 161	The pathophysiology of angiogenesis. [8785263] Crit Rev Oral Biol Med 6(3): 230-47 (1995)
2007 162	Imaging of angiogenesis: clinical techniques and novel imaging methods. [17179341] AJR Am J Roentgenol 188(1): 11-23 (2007)
1983 163	Caldwell Lecture. The collateral circulation: response to ischemia. [6344594] AJR Am J Roentgenol 140(6): 1051-63 (1983)
2008 164	Advances in anatomic, functional, and molecular imaging of angiogenesis. [18375921] J Nucl Med 49(4): 511-4 (2008)
2007 165	Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review). [17549397] Int J Mol Med 20(1): 113-21 (2007)
2003 166	Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development. [15456717] Br J Radiol 76 Spec No 1(-): S83-6 (2003)
2003 167	Angiogenesis imaging in man: a personal view from the pharmaceutical industry. [15456716] Br J Radiol 76 Spec No 1(-): S81-2 (2003)
2003 168	MRI for assessing antivascular cancer treatments. [15456715] Br J Radiol 76 Spec No 1(-): S60-80 (2003)
2003 169	Positron emission tomographic imaging of angiogenesis and vascular function. [15456714] Br J Radiol 76 Spec No 1(-): S50-9 (2003)
2003 170	Angiogenesis imaging--ultrasound. [15456713] Br J Radiol 76 Spec No 1(-): S43-9 (2003)
2003 171	Perfusion CT for the assessment of tumour vascularity: which protocol? [15456712] Br J Radiol 76 Spec No 1(-): S36-42 (2003)
2003 172	Measuring tumour vascular response to antivascular and antiangiogenic drugs. [15456711] Br J Radiol 76 Spec No 1(-): S23-35 (2003)
2003 173	Microenvironmental and cellular consequences of altered blood flow in tumours. [15456710] Br J Radiol 76 Spec No 1(-): S11-22 (2003)
2003 174	Translating angiogenesis research into the clinic: the challenges ahead. [15456709] Br J Radiol 76 Spec No 1(-): S3-10 (2003)
2003 175	Angiogenesis imaging in the post-genomic era. [15456708] Br J Radiol 76 Spec No 1(-): S1-2 (2003)
2008 176	Application of angiogenesis to clinical dermatology. [19256307] Adv Dermatol 24(-): 89-103 (2008)
2005 177	How Avastin potentiates chemotherapeutic drugs: action and reaction in antiangiogenic therapy. [16322683] Cancer Biol Ther 4(12): 1307-10 (2005)
2006 178	Lysyl oxidase (LOX) and hypoxia-induced metastases. [16969095] Cancer Biol Ther 5(8): 909-11 (2006)
2009 179	Imaging of tumor angiogenesis: functional or targeted? [19620425] AJR Am J Roentgenol 193(2): 304-13 (2009)
2008 180	Imaging angiogenesis and the microenvironment. [18834413] APMIS 116(7-8): 695-715 (2008)
2009 181	The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? [19393290] Biochim Biophys Acta 1796(1): 50-4 (2009)
2006 182	New insights regarding vessel regression. [16969103] Cell Cycle 5(18): 2057-9 (2006)
2010 183	Netrin-1 role in angiogenesis: to be or not to be a pro-angiogenic factor? [20372055] Cell Cycle 9(8): 1466-71 (2010)
2011 184	Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. [21274370] World J Gastroenterol 17(4): 409-18 (2011)
2011 185	Imaging techniques used for the real-time assessment of angiogenesis in digestive cancers. [21218077] World J Gastroenterol 17(1): 7-8 (2011)
2007 186	Renal side effects of anti-VEGF therapy in man: a new test system. [17616538] Nephrol Dial Transplant 22(10): 2778-80 (2007)
2008 187	Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. [18591450] Circulation 118(1): 9-16 (2008)
2007 188	Angiogenesis in chronic lung disease. [17356107] Chest 131(3): 874-9 (2007)
2008 189	Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis? [18812560] Radiology 249(2): 510-7 (2008)
2010 190	A miR-thless perspective: how asymmetric dimethylarginine impairs the functions of angiogenic progenitor cells. [20616336] Circ Res 107(1): 12-4 (2010)
2010 191	The role of wnt signaling in physiological and pathological angiogenesis. [20947863] Circ Res 107(8): 943-52 (2010)
2007 192	New targeted angiogenic strategy: bursting bubbles. [17673683] Circ Res 101(3): 232-3 (2007)
2007 193	A novel application for murine double minute 2 antagonists: the p53 tumor suppressor network also controls angiogenesis. [17204660] Circ Res 100(1): 13-4 (2007)
2008 194	Lycat and cloche at the switch between blood vessel growth and differentiation? [18467639] Circ Res 102(9): 1005-7 (2008)
2011 195	Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. [21541193] J Biomed Biotechnol 2011(-): 732848 (2011)
2010 196	ADAM-mediated shedding, a new flavor in angiogenesis regulation. [20962296] Arterioscler Thromb Vasc Biol 30(11): 2087-8 (2010)
2003 197	JAM-1 regulation of endothelial cell migration: implications for angiogenesis. [14672878] Arterioscler Thromb Vasc Biol 23(12): 2119-20 (2003)
2009 198	The opening act: vasculogenesis and the origins of circulation. [19008532] Arterioscler Thromb Vasc Biol 29(5): 623-9 (2009)
2009 199	Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. [19265031] Arterioscler Thromb Vasc Biol 29(5): 639-49 (2009)
2009 200	Kallikrein-kinin system in neovascularization. [19369653] Arterioscler Thromb Vasc Biol 29(5): 617-9 (2009)
2009 201	Endothelial-mural cell signaling in vascular development and angiogenesis. [19164813] Arterioscler Thromb Vasc Biol 29(5): 630-8 (2009)
2008 202	Twin layers of lightning: a new role for the chaperone Hsp90 in angiogenesis. [17975116] Arterioscler Thromb Vasc Biol 28(1): 6-7 (2008)
2007 203	Something is rotten in the state of angiogenesis -- H2S as gaseous stimulator of angiogenesis. [17706951] Cardiovasc Res 76(1): 1-2 (2007)
2011 204	Toll-like receptors in angiogenesis. [21516292] ScientificWorldJournal 11(-): 981-91 (2011)
2007 205	Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. [17334501] Thromb Haemost 97(3): 355-63 (2007)
2003 206	Angiogenesis in endocrine tumors. [14570746] Endocr Rev 24(5): 600-32 (2003)
1997 207	Vascular development: cellular and molecular regulation. [9141503] FASEB J 11(5): 365-73 (1997)
2007 208	Building blood vessels--stem cell models in vascular biology. [17535968] J Cell Biol 177(5): 751-5 (2007)
1999 209	VEGF and vascular fusion: implications for normal and pathological vessels. [10544208] J Histochem Cytochem 47(11): 1351-6 (1999)
2007 210	Antiangiogenesis to treat cancer and intraocular neovascular disorders. [17259997] Lab Invest 87(3): 227-30 (2007)
1986 211	Endothelial cell-matrix interactions: in vitro models of angiogenesis. [2416801] J Histochem Cytochem 34(1): 85-91 (1986)
2002 212	Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. [12382323] Anat Rec 268(3): 252-75 (2002)
2001 213	Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. [11745087] Anat Rec 264(4): 317-24 (2001)
2000 214	Angiogenesis: new insights and therapeutic potential. [10867630] Anat Rec 261(3): 126-35 (2000)
2008 215	Molecular and developmental biology of the hemangioblast. [18429046] Dev Dyn 237(5): 1218-31 (2008)
2007 216	Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. [17557303] Dev Dyn 236(12): 3283-96 (2007)
2004 217	Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. [15376313] Dev Dyn 231(3): 474-88 (2004)
2001 218	The role of FGF and VEGF in angioblast induction and migration during vascular development. [11146503] Dev Dyn 220(1): 1-17 (2001)
1999 219	What guides early embryonic blood vessel formation? [10340752] Dev Dyn 215(1): 2-11 (1999)
2005 220	Tracing the hemangioblast during embryogenesis: developmental relationships between endothelial and hematopoietic cells. [15906241] Int J Dev Biol 49(2-3): 269-77 (2005)
2005 221	Vascular development: from precursor cells to branched arterial and venous networks. [15906240] Int J Dev Biol 49(2-3): 259-67 (2005)
2005 222	Embryonic development of the human hematopoietic system. [15906238] Int J Dev Biol 49(2-3): 243-50 (2005)
2004 223	Development and pathology of the hyaloid, choroidal and retinal vasculature. [15558494] Int J Dev Biol 48(8-9): 1045-58 (2004)
2004 224	Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention. [15349833] Int J Dev Biol 48(5-6): 583-98 (2004)
2002 225	Pathways in blood and vessel development revealed through zebrafish genetics. [12141436] Int J Dev Biol 46(4): 493-502 (2002)
1996 226	The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. [9032025] Int J Dev Biol 40(6): 1189-97 (1996)
2007 227	Notch signaling in vascular development and physiology. [17611219] Development 134(15): 2709-18 (2007)
2007 228	Artery and vein formation: a tug of war between different forces. [17906673] EMBO Rep 8(10): 920-4 (2007)
2005 229	Neural guidance molecules regulate vascular remodeling and vessel navigation. [15879551] Genes Dev 19(9): 1013-21 (2005)
1999 230	Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. [10323857] Genes Dev 13(9): 1055-66 (1999)
2004 231	The diversity of endothelial cells: a challenge for therapeutic angiogenesis. [14759250] Genome Biol 5(2): 207 (2004)
2006 232	Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. [17002866] J Biochem Mol Biol 39(5): 469-78 (2006)
2000 233	The hemostatic system as a regulator of angiogenesis. [10636838] J Biol Chem 275(3): 1521-4 (2000)
1992 234	Angiogenesis. [1375931] J Biol Chem 267(16): 10931-4 (1992)
1998 235	Angiogenesis and vasculogenesis in treatment of cardiovascular disease. [9713822] Mol Med 4(7): 429-40 (1998)
2007 236	Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. [17636133] Proc Natl Acad Sci U S A 104(29): 12140-5 (2007)
2002 237	Won't you be my neighbor? Local induction of arteriogenesis. [12176316] Cell 110(3): 289-92 (2002)
2002 238	Walking the walk: migration and other common themes in blood and vascular development. [11955426] Cell 108(6): 731-4 (2002)
1998 239	Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. [9630209] Cell 93(5): 661-4 (1998)
1996 240	Blood vessel formation: what is its molecular basis? [8980221] Cell 87(7): 1153-5 (1996)
1999 241	Molecular angiogenesis. [10421764] Chem Biol 6(8): R217-24 (1999)
2007 242	Endothelium-microenvironment interactions in the developing embryo and in the adult. [17276337] Dev Cell 12(2): 181-94 (2007)
2004 243	Vascular morphogenesis and the formation of vascular networks. [15068788] Dev Cell 6(4): 479-82 (2004)
2007 244	Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. [17200177] Am J Pathol 170(1): 1-15 (2007)
2001 245	Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. [11238026] Am J Pathol 158(3): 789-96 (2001)
2000 246	Vasculogenic mimicry: how convincing, how novel, and how significant? [10666365] Am J Pathol 156(2): 383-8 (2000)
2000 247	Vasculogenic mimicry and tumor angiogenesis. [10666364] Am J Pathol 156(2): 361-81 (2000)
1999 248	Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name? [10487823] Am J Pathol 155(3): 675-9 (1999)
1998 249	Ocular neovascularization: clarifying complex interactions. [9736014] Am J Pathol 153(3): 665-70 (1998)
1997 250	Vascular endothelial growth factor and ocular neovascularization. [9212726] Am J Pathol 151(1): 13-23 (1997)
1995 251	Between molecules and morphology. Extracellular matrix and creation of vascular form. [7573362] Am J Pathol 147(4): 873-83 (1995)
2004 252	Endothelial progenitor cells for postnatal vasculogenesis. [15308462] Am J Physiol Cell Physiol 287(3): C572-9 (2004)
2002 253	Mechanisms of normal and tumor-derived angiogenesis. [11940508] Am J Physiol Cell Physiol 282(5): C947-70 (2002)
2008 254	Ninein leads the way in vessel sprouting. [19020313] Arterioscler Thromb Vasc Biol 28(12): 2094-5 (2008)
2008 255	Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. [18096826] Arterioscler Thromb Vasc Biol 28(2): 217-22 (2008)
2007 256	Developmental basis of vascular smooth muscle diversity. [17379839] Arterioscler Thromb Vasc Biol 27(6): 1248-58 (2007)
2006 257	Transcriptional regulators of angiogenesis. [16778118] Arterioscler Thromb Vasc Biol 26(9): 1936-47 (2006)
2006 258	Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. [16456096] Arterioscler Thromb Vasc Biol 26(5): 1008-14 (2006)
2006 259	Pericellular proteases in angiogenesis and vasculogenesis. [16469948] Arterioscler Thromb Vasc Biol 26(4): 716-28 (2006)
2005 260	Mechanisms of endothelial differentiation in embryonic vasculogenesis. [16123328] Arterioscler Thromb Vasc Biol 25(11): 2246-54 (2005)
2004 261	Hereditary vascular anomalies: new insights into their pathogenesis. [15231518] Arterioscler Thromb Vasc Biol 24(9): 1578-90 (2004)
2003 262	Endothelial progenitor cells: mobilization, differentiation, and homing. [12714439] Arterioscler Thromb Vasc Biol 23(7): 1185-9 (2003)
2002 263	Re-endothelialization via bone marrow-derived progenitor cells: still another target of statins in vascular disease. [12377721] Arterioscler Thromb Vasc Biol 22(10): 1509-11 (2002)
1997 264	Manipulating angiogenesis. From basic science to the bedside. [9108772] Arterioscler Thromb Vasc Biol 17(4): 605-19 (1997)
1998 265	Review: angiogenesis: implications for rheumatoid arthritis. [9627005] Arthritis Rheum 41(6): 951-62 (1998)
2005 266	Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. [15905185] Blood 106(5): 1525-31 (2005)
2006 267	Akt1 in endothelial cell and angiogenesis. [16552185] Cell Cycle 5(5): 512-8 (2006)
2004 268	Red light, green light: signals that control endothelial cell proliferation during embryonic vascular development. [15611620] Cell Cycle 3(12): 1506-11 (2004)
1997 269	Receptor tyrosine kinase signaling in vascular development. [8993829] Cell Growth Differ 8(1): 3-10 (1997)
2001 270	Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. [11345501] Cell Struct Funct 26(1): 25-35 (2001)
2001 271	Role of ETS family transcription factors in vascular development and angiogenesis. [11345500] Cell Struct Funct 26(1): 19-24 (2001)
2000 272	Collagen XVIII/endostatin structure and functional role in angiogenesis. [10885579] Cell Struct Funct 25(2): 97-101 (2000)
2005 273	Imaging of angiogenesis in inflamed airways and tumors: newly formed blood vessels are not alike and may be wildly abnormal: Parker B. Francis lecture. [16373858] Chest 128(6 Suppl): 602S-608S (2005)
2005 274	Phenotypic diversity of the lung vasculature in experimental models of metastases. [16373855] Chest 128(6 Suppl): 596S-600S (2005)
1988 275	Angiogenesis. State of the art. [2449315] Chest 93(3 Suppl): 159S-166S (1988)
2008 276	Branching morphogenesis. [18845818] Circ Res 103(8): 784-95 (2008)
2008 277	Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. [18369162] Circ Res 102(6): 637-52 (2008)
2007 278	Endothelial precursor cell migration during vasculogenesis. [17641236] Circ Res 101(2): 125-36 (2007)
2007 279	Endothelial cell migration during angiogenesis. [17395884] Circ Res 100(6): 782-94 (2007)
2005 280	Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. [16306453] Circ Res 97(11): 1093-107 (2005)
2005 281	Innate immunity and angiogenesis. [15637304] Circ Res 96(1): 15-26 (2005)
2004 282	Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). [15345667] Circ Res 95(5): 449-58 (2004)
2004 283	Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. [15321945] Circ Res 95(4): 354-63 (2004)
2004 284	Endothelial progenitor cells: characterization and role in vascular biology. [15321944] Circ Res 95(4): 343-53 (2004)
2003 285	Lessons from lymph: flow-guided vessel formation. [12702638] Circ Res 92(7): 701-3 (2003)
2002 286	Role of Akt signaling in vascular homeostasis and angiogenesis. [12089061] Circ Res 90(12): 1243-50 (2002)
2001 287	The putative convergent and divergent natures of angiogenesis and arteriogenesis. [11679402] Circ Res 89(9): 747-9 (2001)
2001 288	Tubes, branches, and pillars: the many ways of forming a new vasculature. [11597985] Circ Res 89(8): 645-7 (2001)
2001 289	Integrins in vascular development. [11577021] Circ Res 89(7): 566-72 (2001)
2001 290	Transcriptional regulation of vascular development. [11532898] Circ Res 89(5): 380-8 (2001)
2001 291	Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix. [11485968] Circ Res 89(3): 195-7 (2001)
2001 292	Transcriptional regulation of vascular development. [11157660] Circ Res 88(2): 127-8 (2001)
2001 293	Control of vascular cell differentiation by homeiobox transcription factors. [11139466] Circ Res 88(1): 7-8 (2001)
2000 294	The role of homeobox genes in vascular remodeling and angiogenesis. [11073881] Circ Res 87(10): 865-72 (2000)
2000 295	Endothelial cell apoptosis in angiogenesis and vessel regression. [10988233] Circ Res 87(6): 434-9 (2000)
2000 296	Akt takes center stage in angiogenesis signaling. [10625297] Circ Res 86(1): 4-5 (2000)
1999 297	Vascular biology in genetically altered mice : smaller vessels, bigger insight. [10590250] Circ Res 85(12): 1214-25 (1999)
1998 298	Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. [9710128] Circ Res 83(3): 342-3 (1998)
1996 299	Molecular mechanisms of coronary collateral vessel growth. [8888683] Circ Res 79(5): 911-9 (1996)
2003 300	Clinician guide to angiogenesis. [14638526] Circulation 108(21): 2613-8 (2003)
2003 301	Angiogenesis: basic pathophysiology and implications for disease. [12657217] Eur Heart J 24(7): 586-603 (2003)
2003 302	Vascular morphogenesis: tales of two syndromes. [12668602] Hum Mol Genet 12 Spec No 1(): R97-112 (2003)
1993 303	Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders. [8406668] Hypertension 22(4): 618-29 (1993)
2000 304	The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. [10675351] J Clin Invest 105(3): 261-70 (2000)
2009 305	Mediators of ocular angiogenesis. [20090210] J Genet 88(4): 495-515 (2009)
1999 306	Role of vascular endothelial growth factor in the regulation of angiogenesis. [10469350] Kidney Int 56(3): 794-814 (1999)
2005 307	The role of pericytes in blood-vessel formation and maintenance. [16212810] Neuro Oncol 7(4): 452-64 (2005)
2005 308	The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. [15831231] Neuro Oncol 7(2): 122-33 (2005)
2005 309	Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy. [15831230] Neuro Oncol 7(2): 106-21 (2005)
2003 310	Mechanism and its regulation of tumor-induced angiogenesis. [12800214] World J Gastroenterol 9(6): 1144-55 (2003)
1997 311	Regulation of vascular morphogenesis by the matricellular protein SPARC. [9150448] Kidney Int 51(5): 1383-7 (1997)
2008 312	Mechanisms of arteriogenesis. [18685784] Acta Biochim Biophys Sin (Shanghai) 40(8): 681-92 (2008)
2010 313	The development of the vasculature and its extracellular matrix: a gradual process defined by sequential cellular and matrix remodeling events. [20543090] Am J Physiol Heart Circ Physiol 299(2): H245-7 (2010)
2009 314	Building a vessel wall with notch signaling. [19246684] Circ Res 104(4): 419-21 (2009)
2011 315	ALK1 as an emerging target for antiangiogenic therapy of cancer. [21467543] Blood 117(26): 6999-7006 (2011)
2005 316	NO role in EPC function. [15747403] Blood 105(5): 1846-7 (2005)
2008 317	The neovasculature homing motif NGR: more than meets the eye. [18574027] Blood 112(7): 2628-35 (2008)
2010 318	Some embryological aspects of cholinergic innervation in the cardiovascular system--a close association with the subintestinal circulatory channel. [20351483] J Pharmacol Sci 112(4): 383-96 (2010)
2003 319	Bone marrow angiogenesis in multiple myeloma: closing in on the loop. [12604399] Haematologica 88(2): 122-4 (2003)
2005 320	Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. [15905966] Cell Mol Life Sci 62(13): 1434-47 (2005)
2011 321	The role of pericytes in angiogenesis. [21710434] Int J Dev Biol 55(3): 261-8 (2011)
2011 322	The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. [21732273] Int J Dev Biol 55(4-5): 495-503 (2011)
2010 323	The Notch pathway in the developing hematopoietic system. [20711994] Int J Dev Biol 54(6-7): 1175-88 (2010)
2010 324	The seminal work of Werner Risau in the study of the development of the vascular system. [20209430] Int J Dev Biol 54(4): 567-72 (2010)
2009 325	Peptide hormone regulation of angiogenesis. [19789380] Physiol Rev 89(4): 1177-215 (2009)
2003 326	CD105 is important for angiogenesis: evidence and potential applications. [12773481] FASEB J 17(9): 984-92 (2003)
2008 327	Mechanisms of angiogenesis. [18707583] Biochemistry (Mosc) 73(7): 751-62 (2008)
2009 328	Glioma angiogenesis: Towards novel RNA therapeutics. [19262177] Cell Adh Migr 3(2): 230-5 (2009)
2009 329	Cell lineages and early patterns of embryonic CNS vascularization. [19270493] Cell Adh Migr 3(2): 205-10 (2009)
2009 330	SRF in angiogenesis: branching the vascular system. [19287204] Cell Adh Migr 3(3): 264-7 (2009)
2009 331	AngiomiRs--key regulators of angiogenesis. [19446450] Curr Opin Genet Dev 19(3): 205-11 (2009)
2010 332	Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer. [20166210] Cancer 116(8): 1859-71 (2010)
2007 333	Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. [17875679] Cancer Res 67(18): 8429-32 (2007)
2009 334	Catecholamines regulate tumor angiogenesis. [19383906] Cancer Res 69(9): 3727-30 (2009)
2010 335	Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. [20010945] Br J Cancer 102(1): 8-18 (2010)
2003 336	Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis. [14562004] Br J Cancer 89(8): 1395-9 (2003)
2003 337	Surrogate markers in antiangiogenesis clinical trials. [12838293] Br J Cancer 89(1): 8-14 (2003)
2008 338	Angiogenesis in pre-malignant conditions. [18941463] Br J Cancer 99(12): 1961-6 (2008)
2003 339	Angiogenesis assays: a critical overview. [12507958] Clin Chem 49(1): 32-40 (2003)
2009 340	Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. [19187003] Antioxid Redox Signal 11(8): 1945-59 (2009)
2009 341	Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis. [19416057] Antioxid Redox Signal 11(8): 1961-74 (2009)
2009 342	Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. [19309262] Antioxid Redox Signal 11(10): 2517-33 (2009)
2005 343	Imaging tumour angiogenesis. [16321775] Cancer Imaging 5(-): 131-8 (2005)
2008 344	Antiangiogenic therapy in brain tumors. [18928341] Expert Rev Neurother 8(10): 1457-73 (2008)
2010 345	Preclinical molecular imaging of tumor angiogenesis. [20639815] Q J Nucl Med Mol Imaging 54(3): 291-308 (2010)
2008 346	Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. [18597583] Physiol Res 57(3): 311-20 (2008)
2011 347	Recent advances in anti-angiogenic therapy of cancer. [21399234] Oncotarget 2(3): 122-34 (2011)
2010 348	Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors. [21317461] Oncotarget 1(7): 662-73 (2010)
2010 349	Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future. [21317448] Oncotarget 1(7): 515-29 (2010)
2009 350	Targeting tumor angiogenesis with histone deacetylase inhibitors. [19111391] Cancer Lett 280(2): 145-53 (2009)
2008 351	Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. [18406051] Cancer Lett 266(1): 37-52 (2008)
2009 352	Molecular regulation of tumor angiogenesis and perfusion via redox signaling. [19374334] Chem Rev 109(7): 3099-124 (2009)
2009 353	Integrins as "functional hubs" in the regulation of pathological angiogenesis. [19482089] Semin Cancer Biol 19(5): 318-28 (2009)
2010 354	Approaches to multimodality imaging of angiogenesis. [20457795] J Nucl Med 51 Suppl 1(-): 66S-79S (2010)
2009 355	Possible novel targets for therapeutic angiogenesis. [19071062] Curr Opin Pharmacol 9(2): 102-8 (2009)
2009 356	Helping the circulatory system heal itself: manipulating kinin signaling to promote neovascularization. [19296754] Expert Rev Cardiovasc Ther 7(3): 215-9 (2009)
2009 357	Angiogenesis in the kidney: a new therapeutic target? [19430335] Curr Opin Nephrol Hypertens 18(2): 160-5 (2009)
2010 358	Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. [20470005] Expert Rev Anticancer Ther 10(5): 729-46 (2010)
2003 359	Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. [12941841] Cancer Res 63(16): 5105-13 (2003)
2004 360	Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation. [15194048] Mol Ther 9(6): 818-28 (2004)
2009 361	Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors. [19664069] FEBS J 276(17): 4653-64 (2009)
2011 362	Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation. [21441136] Circ Res 108(10): 1190-8 (2011)
2011 363	Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel. [21316269] Eur J Vasc Endovasc Surg 41(5): 589-96 (2011)
2009 364	Trpv4 induces collateral vessel growth during regeneration of the arterial circulation. [19017361] J Cell Mol Med 13(8B): 2613-21 (2009)
2010 365	Calcium-dependent signalling is essential during collateral growth in the pig hind limb-ischemia model. [20363225] J Mol Cell Cardiol 49(1): 142-51 (2010)
2012 366	TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling. [21685934] Oncogene 31(2): 200-12 (2012)
2007 367	Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. [17827451] J Clin Oncol 25(26): 4033-42 (2007)
2008 368	Integrins in angiogenesis and lymphangiogenesis. [18497750] Nat Rev Cancer 8(8): 604-17 (2008)
2010 369	Signaling circuitry in vascular morphogenesis. [20216211] Curr Opin Hematol 17(3): 213-8 (2010)
2008 370	Fibroblast growth factor regulation of neovascularization. [18391788] Curr Opin Hematol 15(3): 215-20 (2008)
2010 371	Angiogenesis inhibitors: current strategies and future prospects. [20554717] CA Cancer J Clin 60(4): 222-43 (2010)
2008 372	Foxc2 transcription factor: a newly described regulator of angiogenesis. [19185813] Trends Cardiovasc Med 18(6): 224-8 (2008)
2007 373	Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. [17482097] Trends Cardiovasc Med 17(4): 140-3 (2007)
2007 374	Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization. [17418368] Trends Cardiovasc Med 17(3): 77-83 (2007)
2009 375	Hypoxia-regulated angiogenic inhibitors. [20447566] Trends Cardiovasc Med 19(8): 252-6 (2009)
2008 376	Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. [18855619] Curr Drug Targets 9(10): 851-62 (2008)
2003 377	Regulation by prostaglandin E2 and histamine of angiogenesis in inflammatory granulation tissue. [12772586] Yakugaku Zasshi 123(5): 295-303 (2003)
2010 378	Endothelial colony-forming cell role in neoangiogenesis and tissue repair. [19898235] Curr Opin Organ Transplant 15(1): 68-72 (2010)
2011 379	Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents. [21785569] Sarcoma 2011(-): 165837 (2011)
2011 380	Targeting angiogenesis in childhood sarcomas. [21197468] Sarcoma 2011(-): 601514 (2011)
2007 381	Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. [17473447] Biol Pharm Bull 30(5): 982-4 (2007)
2010 382	Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. [20238301] Histol Histopathol 25(5): 637-46 (2010)
2010 383	Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. [20144623] Microvasc Res 79(3): 200-6 (2010)
2008 384	Computational and mathematical modeling of angiogenesis. [18720228] Microcirculation 15(8): 739-51 (2008)
2002 385	Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. [12214844] J Dent Educ 66(8): 962-75 (2002)
2008 386	Roles of integrins in tumor angiogenesis and lymphangiogenesis. [19093788] Lymphat Res Biol 6(3-4): 155-63 (2008)
2009 387	Multiscale models of angiogenesis. [19349248] IEEE Eng Med Biol Mag 28(2): 14-31 (2009)
2007 388	Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing. [17544023] J Vasc Surg 45 Suppl A(-): A39-47 (2007)
2009 389	Biomarkers of response and resistance to antiangiogenic therapy. [19483739] Nat Rev Clin Oncol 6(6): 327-38 (2009)
2010 390	New insights in synovial angiogenesis. [20022538] Joint Bone Spine 77(1): 13-9 (2010)
2010 391	Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer. [20226736] Lancet Oncol 11(5): 465-75 (2010)
2005 392	Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. [16375664] Curr Cancer Drug Targets 5(8): 579-94 (2005)
2010 393	EGFL7 meets miRNA-126: an angiogenesis alliance. [20529320] J Angiogenes Res 2(1): 9 (2010)
2009 394	Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. [19946412] J Angiogenes Res 1(-): 4 (2009)
2010 395	Molecular mediators of angiogenesis. [20061852] J Burn Care Res 31(1): 158-75 (2010)
2010 396	The mouse retina as an angiogenesis model. [20484600] Invest Ophthalmol Vis Sci 51(6): 2813-26 (2010)
2008 397	New molecular targets in angiogenic vessels of glioblastoma tumours. [18684337] Expert Rev Mol Med 10(-): e23 (2008)
2007 398	Tumour vascularization: sprouting angiogenesis and beyond. [17717633] Cancer Metastasis Rev 26(3-4): 489-502 (2007)
2008 399	The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. [18058195] Cancer Metastasis Rev 27(1): 57-66 (2008)
2008 400	Clinical biomarkers of angiogenesis inhibition. [18414993] Cancer Metastasis Rev 27(3): 415-34 (2008)
2008 401	Targeting vasculature in urologic tumors: mechanistic and therapeutic significance. [17668426] J Cell Biochem 103(3): 691-708 (2008)
2010 402	The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. [20688566] Trends Mol Med 16(9): 417-25 (2010)
2011 403	Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior. [21949569] World J Biol Chem 2(9): 193-201 (2011)
2010 404	Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis. [21537462] World J Biol Chem 1(10): 291-7 (2010)
2008 405	Matrix metalloproteinase control of capillary morphogenesis. [18540825] Crit Rev Eukaryot Gene Expr 18(3): 251-78 (2008)
2011 406	Rat mesentery angiogenesis assay. [21712799] J Vis Exp -(52): - (2011)
2009 407	Notch signalling in ischaemia-induced angiogenesis. [19909251] Biochem Soc Trans 37(Pt 6): 1221-7 (2009)
2011 408	The roles of microRNAs in tumorigenesis and angiogenesis. [21760972] Int J Physiol Pathophysiol Pharmacol 3(2): 140-55 (2011)
2010 409	Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. [19752562] Int Arch Allergy Immunol 151(2): 89-97 (2010)
2008 410	Anti-angiogenesis: making the tumor vulnerable to the immune system. [18438662] Cancer Immunol Immunother 57(10): 1553-8 (2008)
2008 411	Multicellular sprouting during vasculogenesis. [18023731] Curr Top Dev Biol 81(-): 269-89 (2008)
2009 412	Transcriptional control of endothelial cell development. [19217421] Dev Cell 16(2): 180-95 (2009)
2011 413	Nanotechnology-mediated targeting of tumor angiogenesis. [21349160] Vasc Cell 3(1): 3 (2011)
2011 414	Vaccines targeting the neovasculature of tumors. [21385454] Vasc Cell 3(1): 7 (2011)
2011 415	Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy. [22082307] Vasc Cell 3(-): 26 (2011)
2011 416	Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. [21923938] Vasc Cell 3(1): 20 (2011)
2009 417	Angiogenesis in rheumatoid arthritis. [19863375] Autoimmunity 42(7): 563-73 (2009)
2011 418	Anti-angiogenic peptides for cancer therapeutics. [21470139] Curr Pharm Biotechnol 12(8): 1101-16 (2011)
2010 419	Systems biology of pro-angiogenic therapies targeting the VEGF system. [20890966] Wiley Interdiscip Rev Syst Biol Med 2(6): 694-707 (2010)
PMC 420	Vascular endothelial growth factor signaling regulates the segregation of artery and vein via ERK activity during vascular development. [23266606] Biochem Biophys Res Commun 430(4):1212-6 (2013)
PMC 421	Lipid phosphate phosphatase (LPP3) and vascular development. [22835522] Biochim Biophys Acta 1831(1):126-32 (2013)
PMC 422	S1P1 bridges mechanotransduction and angiogenesis during vascular development. [22975318] Dev Cell 23(3):451-2 (2012)
PMC 423	Nerve control of blood vessel patterning. [23449469] Dev Cell 24(4):340-1 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Angiogenesis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Angiogenesis.php on line 92